Jill Kolesar

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Athanassios Argiris, Musie Ghebremichael, Jill Gilbert et al. · Journal of Clinical Oncology · 2013 · 208 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

David Delgado, Jacquelyn A. Hank, Jill Kolesar et al. · Cancer Research · 2010 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

Christopher J. Sweeney, Glenn Liu, Constantin T. Yiannoutsos et al. · Clinical Cancer Research · 2005 · 173 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion

Douglas G. McNeel, Jens C. Eickhoff, Fred T. Lee et al. · Clinical Cancer Research · 2005 · 158 citations

Medicine, Oncology, Pharmacology +17

A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer

Lynn Van Ummersen, Kim Binger, Jennifer Volkman et al. · Clinical Cancer Research · 2004 · 157 citations

Medicine, Oncology, Pharmacology +14